Open AccessPB2033: INFLUENCE OF INDUCTION THERAPY WITH LENALIDOMIDE ON MAINTENANCE THERAPY AND PROGNOSIS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
Author(s) -
Sun Q.,
Liu J.,
Huang B.,
Gu J.,
Li X.,
Li J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000850964.23300.15
Subject(s) - medicine , multiple myeloma , discontinuation , maintenance therapy , autologous stem cell transplantation , bortezomib , melphalan , lenalidomide , surgery , transplantation , dexamethasone , hematopoietic stem cell transplantation , oncology , chemotherapy